Mimic of Peritoneal Carcinomatosis: Protein-Losing Enteropathy Revealing HRAS-Driven Generalized Lymphatic Anomaly. (PubMed, ACG Case Rep J) - Oct 14, 2026 - "Alternating therapy of sirolimus and trametinib is ongoing. This is the first reported case of protein-losing enteropathy as the presenting manifestation of an HRAS-driven generalized lymphatic anomaly."
Journal • Oncology • Peritoneal Cancer • HRAS
|
|
Ahmad Al-Huniti; Joshua Peterson; Sahil Khanna; Scott Thompson; Stephanie Saey; Vijayvardhan Kamalumpundi
|